Skip to main content
. 2020 Oct 14;20:447. doi: 10.1186/s12872-020-01733-5

Table 2.

Comparison of readmission rates and mortality according to the treatment received (n = 100)

Early ultrafiltration group (n = 40) Torasemide plus tolvaptan group (n = 60) P-value
1-month follow-up
 Readmission rates (%) 7 (17.5) 12 (20.0) 0.755
 Mortality (%) 0 (0.0) 1 (1.7) 1.000
3-months follow-up
 Readmission rates (%) 8 (20.0) 22 (36.7) 0.075
 Mortality (%) 0 (0.0) 1 (1.7) 1.000